Literature DB >> 16301178

Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines.

Haiyan Li1, Clarissa L Waites, Roland G Staal, Yuriy Dobryy, Jeanna Park, David L Sulzer, Robert H Edwards.   

Abstract

The release of monoamine neurotransmitters from cell bodies and dendrites has an important role in behavior, but the mechanism (vesicular or non vesicular) has remained unclear. Because the location of vesicular monoamine transporter 2 (VMAT2) defines the secretory vesicles capable of monoamine release, we have studied its trafficking to assess the potential for monoamine release by exocytosis. In neuroendocrine PC12 cells, VMAT2 localizes exclusively to large dense-core vesicles (LDCVs), and we now show that cytoplasmic signals target VMAT2 directly to LDCVs within the biosynthetic pathway. In neurons, VMAT2 localizes to a population of vesicles that we now find undergo regulated exocytosis in dendrites. Although hippocampal neurons do not express typical LDCV proteins, transfected chromogranins A, B, and brain-derived neurotrophic factor (BDNF) colocalize with VMAT2. VMAT2 thus defines a population of secretory vesicles that mediate the activity-dependent somatodendritic release of multiple retrograde signals involved in synaptic function, growth, and plasticity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301178     DOI: 10.1016/j.neuron.2005.09.033

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  37 in total

1.  Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.

Authors:  Bibiana Onoa; Haiyan Li; Johann A Gagnon-Bartsch; Laura A B Elias; Robert H Edwards
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

3.  v-SNARE composition distinguishes synaptic vesicle pools.

Authors:  Zhaolin Hua; Sergio Leal-Ortiz; Sarah M Foss; Clarissa L Waites; Craig C Garner; Susan M Voglmaier; Robert H Edwards
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

4.  Imaging of evoked dense-core-vesicle exocytosis in hippocampal neurons reveals long latencies and kiss-and-run fusion events.

Authors:  Xiaofeng Xia; Volkmar Lessmann; Thomas F J Martin
Journal:  J Cell Sci       Date:  2008-12-09       Impact factor: 5.285

5.  A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.

Authors:  Anna Grygoruk; Hao Fei; Richard W Daniels; Bradley R Miller; Aaron Diantonio; David E Krantz
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 6.  Synaptic vesicle protein trafficking at the glutamate synapse.

Authors:  M S Santos; H Li; S M Voglmaier
Journal:  Neuroscience       Date:  2008-03-22       Impact factor: 3.590

7.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

8.  Self-assembly of VPS41 promotes sorting required for biogenesis of the regulated secretory pathway.

Authors:  Cédric S Asensio; Daniel W Sirkis; James W Maas; Kiyoshi Egami; Tsz-Leung To; Frances M Brodsky; Xiaokun Shu; Yifan Cheng; Robert H Edwards
Journal:  Dev Cell       Date:  2013-11-07       Impact factor: 12.270

9.  Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system.

Authors:  M K-H Schafer; S K Mahata; N Stroth; L E Eiden; E Weihe
Journal:  Regul Pept       Date:  2009-12-18

Review 10.  Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Authors:  Annette E Fleckenstein; Trent J Volz; Glen R Hanson
Journal:  Neuropharmacology       Date:  2008-07-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.